Dendritic cell reprogramming by the hypoxic environment

Immunobiology

Volumn 217, Issue 12, 2012, Pages 1241-1249

  Bosco, Maria Carla ^a   Varesio, Luigi ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Chemokines receptors; Dendritic cells; Gene regulation; Hypoxia; Immunoregulatory receptors; Inflammation

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; HYPOXIA INDUCIBLE FACTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; DNA STRUCTURE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HYPOXIA; HYPOXIA RESPONSIVE ELEMENT; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; MICROENVIRONMENT; PRIORITY JOURNAL;

CELL HYPOXIA; DENDRITIC CELLS; GENE EXPRESSION; HUMANS; MONOCYTES; OXYGEN;

EID: 84869097204     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.07.023     Document Type: Article

References (103)

1. Allavena P., Sica A., Vecchi A., Locati M., Sozzani S., Mantovani A. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol. Rev. 2000, 177:141-149.
2. Battaglia F., Delfino S., Merello E., Puppo M., Piva R., Varesio L., Bosco M.C. Hypoxia transcriptionally induces macrophage-inflammatory protein-3{alpha}/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-κB. J. Leukoc. Biol. 2008, 83:648-662.
3. Beyer C., Schett G., Gay S., Distler O., Distler J.H. Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis. Arthritis Res. Ther. 2009, 11:220.
4. Bjornheden T., Levin M., Evaldsson M., Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler. Thromb. Vasc. Biol. 1999, 19:870-876.
5. Blengio F., Raggi F., Pierobon D., Cappello P., Eva A., Giovarelli M., Varesio L., Bosco M.C. The hypoxic environment reprograms the cytokine/chemokine expression profile of human mature dendritic cells. Immunobiology 2012.
6. Bobryshev Y.V. Dendritic cells and their role in atherogenesis. Lab. Invest. 2010, 90:970-984.
7. Bosco M.C., Varesio L. Monocytic cell gene regulation by the hypoxic synovial environment in juvenile idiopathic arthritis: implications for disease pathogenesis. J. Clin. Rheumatol. Musculoskelet. Med. 2010, 1:47-55.
8. Bosco M.C., Delfino S., Ferlito F., Battaglia F.P.M., Gregorio A., Gambini C., Gattorno M., Martini A., Varesio L. Hypoxic synovial environment and expression of macrophage inflammatory protein MIP-3α/CCL20 in juvenile idiopathic arthritis. Arthritis Rheum. 2008, 58:1833-1838.
9. Bosco M.C., Delfino S., Ferlito F., Puppo M., Gregorio A., Gambini C., Gattorno M., Martini A., Varesio L. The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis. J. Rheumatol. 2009, 36:1318-1329.
10. Bosco M.C., Pierobon D., Blengio F., Raggi F., Vanni C., Gattorno M., Eva A., Novelli F., Cappello P., Giovarelli M., Varesio L. Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 2011, 117:2625-2639.
11. Bosco M.C., Puppo M., Blengio F., Fraone T., Cappello P., Giovarelli M., Varesio L. Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 2008, 213:733-749.
12. Bosco M.C., Puppo M., Santangelo C., Anfosso L., Pfeffer U., Fardin P., Battaglia F., Varesio L. Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J. Immunol. 2006, 177:1941-1955.
13. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000, 164:4991-4995.
14. Brand S. Crohn's disease: Th1, Th17 or both?. The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009, 58:1152-1167.
15. Caldwell C.C., Kojima H., Lukashev D., Armstrong J., Farber M., Apasov S.G., Sitkovsky M.V. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 2001, 167:6140-6149.
16. Carraro F., Pucci A., Pellegrini M., Pelicci P.G., Baldari C.T., Naldini A. p66Shc is involved in promoting HIF-1alpha accumulation and cell death in hypoxic T cells. J. Cell. Physiol. 2007, 211:439-447.
17. Cavanagh L.L., Von Andrian U.H. Travellers in many guises: the origins and destinations of dendritic cells. Immunol. Cell Biol. 2002, 80:448-462.
18. Chabowski A., Gorski J., Calles-Escandon J., Tandon N.N., Bonen A. Hypoxia-induced fatty acid transporter translocation increases fatty acid transport and contributes to lipid accumulation in the heart. FEBS Lett. 2006, 580:3617-3623.
19. Collins C.E., La D.T., Yang H.T., Massin F., Gibot S., Faure G., Stohl W. Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann. Rheum. Dis. 2009, 68:1768-1774.
20. Colonna M., Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J. Infect. Dis. 2003, 187(Suppl 2):S397-S401.
21. Colonna M., Nakajima H., Cella M. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin. Immunol. 2000, 12:121-127.
22. Cramer T., Yamanishi Y., Clausen B.E., Förster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., Firestein G.S., Gerber H.-P., Ferrara N., Johnson R.S. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657.
23. Crowther M., Brown N.J., Bishop E.T., Lewis C.E. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukoc. Biol. 2001, 70:478-490.
24. Cummins E.P., Taylor C.T. Hypoxia-responsive transcription factors. Pflugers Arch. 2005, 450:363-371.
25. de Jong E.C., Smits H.H., Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 2005, 26:289-307.
26. Di Cesare A., Di Meglio P., Nestle F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J. Invest. Dermatol. 2009, 129:1339-1350.
27. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
28. Dubsky P., Ueno H., Piqueras B., Connoly J., Banchereau J., Palucka A.K. Human dendritic cell subsets for vaccination. J. Clin. Immunol. 2005, 25:551-572.
29. Elia A.R., Cappello P., Puppo M., Fraone T., Vanni C., Eva A., Musso T., Novelli F., Varesio L., Giovarelli M. Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J. Leukoc. Biol. 2008, 84:1472-1482.
30. Fang H.Y., Hughes R., Murdoch C., Coffelt S.B., Biswas S.K., Harris A.L., Johnson R.S., Imityaz H.Z., Simon M.C., Fredlund E., Greten F.R., Rius J., Lewis C.E. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 2009, 114:844-859.
31. Foell D., Wittkowski H., Roth J. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 2007, 3:382-390.
32. Foti M., Ricciardi-Castagnoli P., Granucci F. Gene expression profiling of dendritic cells by microarray. Methods Mol. Biol. 2007, 380:215-224.
33. Frede S., Stockmann C., Winning S., Freitag P., Fandrey J. Hypoxia-inducible factor (HIF) 1alpha accumulation and HIF target gene expression are impaired after induction of endotoxin tolerance. J. Immunol. 2009, 182:6470-6476.
34. Geissmann F., Gordon S., Hume D.A., Mowat A.M., Randolph G.J. Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 2010, 10:453-460.
35. Gerber J.S., Mosser D.M. Stimulatory and inhibitory signals originating from the macrophage Fcgamma receptors. Microbes Infect. 2001, 3:131-139.
36. Granucci F., Zanoni I., Ricciardi-Castagnoli P. Central role of dendritic cells in the regulation and deregulation of immune responses. Cell. Mol. Life Sci. 2008, 65:1683-1697.
37. Harris A.L. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2:38-47.
38. Hume D.A. Macrophages as APC and the dendritic cell myth. J. Immunol. 2008, 181:5829-5835.
39. Imtiyaz H.Z., Simon M.C. Hypoxia-inducible factors as essential regulators of inflammation. Curr. Top. Microbiol. Immunol. 2010, 345:105-120.
40. Jantsch J., Chakravortty D., Turza N., prechtel A.T., Buchholtz B., Gerlach R.G., Volke M., Glasner J., Warnecke C., Wiesener M.S., Eckardt K.U., Steinkasserer A., Hensel M., William C. Hypoxia and Hypoxia-Inducible Factor-1{alpha} Modulate Lipopolysaccharide-Induced Dendritic Cell Activation and Function. J. Immunol. 2008, 180:4697-4705.
41. Jantsch J., Wiese M., Schodel J., Castiglione K., Glasner J., Kolbe S., Mole D., Schleicher U., Eckardt K.U., Hensel M., Lang R., Bogdan C., Schnare M., Willam C. Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1alpha (HIF1A) and result in differential HIF1A-dependent gene expression. J. Leukoc. Biol. 2011, 90:551-562.
42. Kanazawa N. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells. J. Dermatol. Sci. 2007, 45:77-86.
43. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003, 3:984-993.
44. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
45. Knowles H.J., Harris A.L. Macrophages and the hypoxic tumour microenvironment. Front. Biosci. 2007, 12:4298-4314.
46. Kuhlicke J., Frick J.S., Morote-Garcia J.C., Rosenberger P., Eltzschig H.K. Hypoxia inducible factor (HIF)-1 coordinates induction of toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2007, 2:e1364.
47. Landi A., Babiuk L.A., van Drunen Littel-van den Hurk Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-alpha or LPS. Immunobiology 2011, 216:649-662.
48. Lanzavecchia A., Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001, 106:263-266.
49. Lebre M.C., Tak P.P. Dendritic cells in rheumatoid arthritis: which subset should be used as a tool to induce tolerance?. Hum. Immunol. 2009, 70:321-324.
50. Lin A., Schildknecht A., Nguyen L.T., Ohashi P.S. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol. Lett. 2010, 127:77-84.
51. Lin K.W., Jacek T., Jacket R. Dendritic cells heterogeneity and its role in cancer immunity. Cancer Res. Ther. 2006, 2:35-40.
52. Lutzky V., Hannawi S., Thomas R. Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res. Ther. 2007, 9:219.
53. Mancino A., Schioppa T., Larghi P., Pasqualini F., Nebuloni M., Chen I.H., Sozzani S., Austyn J.M., Mantovani A., Sica A. Divergent effects of hypoxia on dendritic cell functions. Blood 2008, 112:3723-3734.
54. Mantovani A., Savino B., Locati M., Zammataro L., Allavena P., Bonecchi R. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 2010, 21:27-39.
55. Melillo G., Musso T., Sica A., Taylor L.S., Cox G., Varesio L. A hypoxia responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 1995, 182:1683.
56. Mi Z., Rapisarda A., Taylor L., Brooks A., Creighton-Gutteridge M., Melillo G., Varesio L. Synergystic induction of HIF-1alpha transcriptional activity by hypoxia and lipopolysaccharide in macrophages. Cell Cycle 2007, 7.
57. Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 2000, 1:199-205.
58. Murakami M., Iwai S., Hiratsuka S., Yamauchi M., Nakamura K., Iwakura Y., Shibuya M. Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages. Blood 2006, 108:1849-1856.
59. Murdoch C., Giannoudis A., Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104:2224-2234.
60. Muz B., Khan M.N., Kiriakidis S., Paleolog E.M. Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis. Arthritis Res. Ther. 2009, 11:201.
61. Naldini A., Morena E., Pucci A., Miglietta D., Riboldi E., Sozzani S., Carraro F. Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1alpha and lipopolysaccharide. J. Cell. Physiol. 2012, 227:587-595.
62. Nistala K., Moncrieffe H., Newton K.R., Varsani H., Hunter P., Wedderburn L.R. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 2008, 58:875-887.
63. Nizet V., Johnson R.S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 2009, 9:609-617.
64. O'Regan A.W., Nau G.J., Chupp G.L., Berman J.S. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol. Today 2000, 21:475-478.
65. Ogino T., Onishi H., Suzuki H., Morisaki T., Tanaka M., Katano M. Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions. Cancer Immunol. Immunother. 2011.
66. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., Hurtado-Ziola N., Nizet V., Johnson R.S. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 2005, 115:1806-1815.
67. Qu X., Yang M.X., Kong B.H., Qi L., Lam Q.L., Yan S., Li P., Zhang M., Lu L. Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol. Cell Biol. 2005, 83:668-673.
68. Rama I., Brune B., Torras J., Koehl R., Cruzado J.M., Bestard O., Franquesa M., Lloberas N., Weigert A., Herrero-Fresneda I., Gulias O., Grinyo J.M. Hypoxia stimulus: an adaptive immune response during dendritic cell maturation. Kidney Int. 2008, 73:816-825.
69. Ricciardi A., Elia A.R., Cappello P., Puppo M., Vanni C., Fardin P., Eva A., Munroe D., Wu X., Giovarelli M., Varesio L. Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol. Cancer Res. 2008, 6:175-185.
70. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., Johnson R.S., Haddad G.G., Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811.
71. Robbins S.H., Walzer T., Dembele D., Thibault C., Defays A., Bessou G., Xu H., Vivier E., Sellars M., Pierre P., Sharp F.R., Chan S., Kastner P., Dalod M. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 2008, 9:R17.
72. Roiniotis J., Dinh H., Masendycz P., Turner A., Elsegood C.L., Scholz G.M., Hamilton J.A. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J. Immunol. 2009, 182:7974-7981.
73. Rossi M., Young J.W. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 2005, 175:1373-1381.
74. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 1998, 19:568-574.
75. Schakel K. Dendritic cells - why can they help and hurt us. Exp. Dermatol. 2009, 18:264-273.
76. Schutyser E., Struyf S., Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003, 14:409-426.
77. Semenza G.L. Oxygen sensing, homeostasis, and disease. N. Engl. J. Med. 2011, 365:537-547.
78. Senger D.R., Ledbetter S.R., Claffey K.P., Papadopoulos-Sergiou A., Peruzzi C.A., Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am. J. Pathol. 1996, 149:293-305.
79. Sharif O., Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008, 213:701-713.
80. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19-30.
81. Sica A., Melillo G., Varesio L. Hypoxia: a double-edged sword of immunity. J. Mol. Med. (Berl.) 2011, 89:657-665.
82. Sitkovsky M., Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 2008, 5:712-721.
83. Smolewska E., Stanczyk J., Brozik H., Biernacka-Zielinska M., Cebula B., Robak T., Smolewski P. Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis. Ann. Rheum. Dis. 2008, 67:762-768.
84. Sozzani S. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev. 2005, 16:581-592.
85. Spirig R., Djafarzadeh S., Regueira T., Shaw S.G., von Garnier C., Takala J., Jakob S.M., Rieben R., Lepper P.M. Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions. PLoS One 2010, 5:e0010983.
86. Staples K.J., Sotoodehnejadnematalahi F., Pearson H., Frankenberger M., Francescut L., Ziegler-Heitbrock L., Burke B. Monocyte-derived macrophages matured under prolonged hypoxia transcriptionally up-regulate HIF-1alpha mRNA. Immunobiology 2011, 216:832-839.
87. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
88. Sun J., Zhang Y., Yang M., Zhang Y., Xie Q., Li Z., Dong Z., Yang Y., Deng B., Feng A., Hu W., Mao H., Qu X. Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A(2). Cell Mol. Immunol. 2010, 7:77-82.
89. Tang Z., Saltzaman A. Understanding human dendritic cell biology through gene profiling. Inflamm. Res. 2004, 53:424-441.
90. Tessarz A.S., Cerwenka A. The TREM-1/DAP12 pathway. Immunol. Lett. 2008, 116:111-116.
91. Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., Di Pucchio T., Connolly J., Fay J.W., Pascual V., Palucka A.K., Banchereau J. Dendritic cell subsets in health and disease. Immunol. Rev. 2007, 219:118-142.
92. Vaupel P., Hockel M. Tumor oxygenation and its relevance to tumor physiology and treatment. Adv. Exp. Med. Biol. 2003, 510:45-49.
93. Vink A., Schoneveld A.H., Lamers D., Houben A.J., van der G.P., van Diest P.J., Pasterkamp G. HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis 2007, 195:e69-e75.
94. Vissers J.L., Hartgers F.C., Lindhout E., Teunissen M.B., Figdor C.G., Adema G.J. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J. Leukoc. Biol. 2001, 69:785-793.
95. Vulcano M., Struyf S., Scapini P., Cassatella M., Bernasconi S., Bonecchi R., Calleri A., Penna G., Adorini L., Luini W., Mantovani A., Van Damme J., Sozzani S. Unique regulation of CCL18 production by maturing dendritic cells. J. Immunol. 2003, 170:3843-3849.
96. Wang Q., Liu C., Zhu F., Liu F., Zhang P., Guo C., Wang X., Li H., Ma C., Sun W., Zhang Y., Chen W., Zhang L. Reoxygenation of hypoxia-differentiated dendritic cells induces Th1 and Th17 cell differentiation. Mol. Immunol. 2010, 47:922-931.
97. Wedderburn L.R., Robinson N., Patel A., Varsani H., Woo P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum. 2000, 43:765-774.
98. Wenger R.H., Stiehl D.P., Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci. STKE 2005, re12.
99. Wenink M.H., van den Berg W.B., van Riel P.L., Radstake T.R. Fc gamma receptor mediated modulation of dendritic cells as a potential strategy in the battle against rheumatoid arthritis. Neth. J. Med. 2006, 64:103-108.
100. Yang M., Ma C., Liu S., Shao Q., Gao W., Song B., Sun J., Xie Q., Zhang Y., Feng A., Liu Y., Hu W., Qu X. HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia. Immunol. Cell Biol. 2010, 88:165-171.
101. Yang M., Ma C., Liu S., Sun J., Shao Q., Gao W., Zhang Y., Li Z., Xie Q., Dong Z., Qu X. Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin. Immunology 2009, 128:e237-e249.
102. Zhao P., Li X., Yang M., Shao Q., Wang D., Liu S., Song H., Song B., Zhang Y., Qu X. Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A(2b) via cAMP/PKA signaling pathway. Mol. Immunol. 2008, 2187-2195.
103. Zinkernagel A.S., Johnson R.S., Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J. Mol. Med. (Berl.) 2007, 85:1339-1346.